financetom
Business
financetom
/
Business
/
Robinhood Markets Insider Sold Shares Worth $1,803,982, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Robinhood Markets Insider Sold Shares Worth $1,803,982, According to a Recent SEC Filing
Dec 17, 2024 12:58 AM

03:32 AM EST, 12/17/2024 (MT Newswires) -- Baiju Bhatt, Director, on December 12, 2024, sold 45,077 shares in Robinhood Markets ( HOOD ) for $1,803,982. Following the Form 4 filing with the SEC, Bhatt has control over a total of 2,521 shares of the company, with 2,521 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1783879/000178387924000335/xslF345X05/wk-form4_1734391910.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs
Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs
Jul 3, 2024
09:16 AM EDT, 07/03/2024 (MT Newswires) -- Stellantis NV ( STLA ) said Wednesday it will collaborate with the French research organization CEA over the next five years to design next-generation battery cells for electric vehicles. The joint program includes designing advanced technology cells that provide a higher performance, longer lifespan and lower carbon footprint, Stellantis ( STLA ) said....
SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune
SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune
Jul 3, 2024
09:15 AM EDT, 07/03/2024 (MT Newswires) -- SeaStar Medical Holding ( ICU ) said Wednesday that the US Food and Drug Administration has agreed to the final labeling for its Quelimmune device to treat children with acute kidney injury and sepsis or septic condition requiring kidney replacement therapy. The commercial-stage medical technology company said the final labeling paves the way...
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal
Jul 3, 2024
July 3 (Reuters) - Quest Diagnostics ( DGX ) said on Wednesday it would acquire Canada-based LifeLabs from pension plan owner OMERS for about C$1.35 billion, or about $985 million, including net debt. LifeLabs, which provides community laboratory tests, would retain its brand, Canadian headquarters and management after the acquisition is closed. The U.S. laboratory operator will acquire 100% of...
BRIEF-Paramount And Skydance Deal Expected To Be Completed By The Weekend- CNBC Citing Sources
BRIEF-Paramount And Skydance Deal Expected To Be Completed By The Weekend- CNBC Citing Sources
Jul 3, 2024
July 3 (Reuters) - * PARAMOUNT AND SKYDANCE DEAL EXPECTED TO BE COMPLETED BY THE WEEKEND- CNBC CITING SOURCES ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved